New drug combo shows promise in targeting RAS-mutant multiple myeloma

The combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.

Patients wants test results now, and radiologists need time to explain. Can they meet in the middle?

One of the hardest parts about getting an X-ray or a CT scan is the wait. Sometimes it takes days, or even weeks, for medical

December 1, 2023

Reports of telehealth’s death have been greatly exaggerated

“Telehealth is collapsing.” “Telehealth is going through a contraction.” “There is a dark cloud hovering over virtual care.” These are just a few of the

May 21, 2024

ASCO 2024: J&J’s early radioligand prostate cancer trial reports four patient deaths – Pharmaceutical Technology

J&J’s asset works by delivering an actinium-based radioligand which emits high-energy short-range alpha particles. Image credit: Shutterstock/Jurik Peter. Johnson & Johnson’s (J&J) prostate cancer radiotherapy

May 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.